Device
CG-100 Intraluminal Bypass Device
CG-100 Intraluminal Bypass Device is a medical device with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
recruiting267%
unknown133%
Recent Activity
2 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT04184973Not Applicable
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
NCT05632744Not Applicable
Evaluation of CG-100 Intraluminal Bypass Device
NCT03423485Not Applicable
Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery.
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3